Ralstonia species – do these bacteria matter in cystic fibrosis?

Coenye, 2002, Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov, J Clin Microbiol, 40, 2062, 10.1128/JCM.40.6.2062-2069.2002 Lipuma, 2010, The changing microbial epidemiology in cystic fibrosis, Clin Microbiol Rev, 23, 299, 10.1128/CMR.00068-09 Zhang, 2016, Phylogenomic analysis of the genus Ralstonia based on 686 single-copy genes, Antonie van Leeuwenhoek, 109, 71, 10.1007/s10482-015-0610-4 Stelzmueller, 2006, Ralstonia pickettii-innocent bystander or a potential threat?, Clin Microbiol Infect, 12, 99, 10.1111/j.1469-0691.2005.01309.x Coenye, 2005, Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis, J Clin Microbiol, 43, 3463, 10.1128/JCM.43.7.3463-3466.2005 Parkinson, 2013, Application of variable-number tandem-repeat typing to discriminate Ralstonia solanacearum strains associated with English watercourses and disease outbreaks, Appl Environ Microbiol, 79, 6016, 10.1128/AEM.01219-13 Boutros, 2002, Ralstonia pickettii traced in blood culture bottles, J Clin Microbiol, 40, 2666, 10.1128/JCM.40.7.2666-2667.2002 Barbut, 2006, Outbreak of Ralstonia pickettii pseudobacteremia among patients with haematological malignancies, Infect Control Hosp Epidemiol, 37, 642, 10.1086/505100 Coenye, 2003, Ralstonia respiraculi sp. nov., isolated from the respiratory tract of cystic fibrosis patients, Int J Syst Evol Microbiol, 53, 1339, 10.1099/ijs.0.02440-0 Moreira, 2005, Ralstonia pickettii and Burkholderia cepacia complex bloodstream infections related to infusion of contaminated water for injection, J Hosp Infect, 60, 51, 10.1016/j.jhin.2004.09.036 Maroye, 2000, Investigation of an outbreak of Ralstonia pickettii in a paediatric hospital by RAPD, J Hosp Infect, 44, 267, 10.1053/jhin.1999.0691 Coenye, 2002, Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction, Emerg Infect Dis, 8, 692, 10.3201/eid0807.010472 Kendirli, 2004, Ralstonia pickettii outbreak associated with contaminated distilled water used for respiratory care in a paediatric intensive care unit, J Hosp Infect, 56, 77, 10.1016/j.jhin.2003.09.011 Block, 2013, Deja vu: Ralstonia mannitolilytica infection associated with a humidifying respiratory therapy device, Israel, June to July 2011, Euro Surveill, 18, 20471, 10.2807/ese.18.18.20471-en Centers for Disease Control, 2005, Ralstonia associated with Vapotherm oxygen delivery device–United States, 2005, MMWR Morb Mortal Wkly Rep, 54, 1052 Labarca, 1999, A multistate nosocomial outbreak of Ralstonia pickettii colonization associated with an intrinsically contaminated respiratory care solution, Clin Infect Dis, 29, 1281, 10.1086/313458 Mcneil, 1985, Nosocomial Pseudomonas pickettii colonization associated with a contaminated respiratory therapy solution in a special care nursery, J Clin Microbiol, 22, 903, 10.1128/jcm.22.6.903-907.1985 Jhung, 2007, A national outbreak of Ralstonia mannitolilytica associated with use of a contaminated oxygen-delivery device among pediatric patients, Pediatrics, 119, 1061, 10.1542/peds.2006-3739 Saiman, 2014, Infection prevention and control guideline for cystic fibrosis: 2013 update, Infect Control Hosp Epidemiol, 35, S1, 10.1086/676882 Perry, 2015, Ralstonia mannitolilytica – an emerging threat in cystic fibrosis and lung transplantation, J Cyst Fibros, 14, S72, 10.1016/S1569-1993(15)30236-8 Dogan, 2010, Isolation of Ralstonia insidiosa from cystic fibrosis patients in a Turkish university hospital, Clin Microbiol Infect, 16 Green, 2015, Gram-negative emerging pathogens: prevalence and strain typing results from a large UK adult CF centre, J Cyst Fibros, 14, S68, 10.1016/S1569-1993(15)30220-4 Ryan, 2014, Ralstonia spp.: emerging global opportunistic pathogens, Eur J Clin Microbiol Infect Dis, 33, 291, 10.1007/s10096-013-1975-9 Flight, 2015, Rapid detection of emerging pathogens and loss of microbial diversity associated with severe lung disease in cystic fibrosis, J Clin Microbiol, 53, 2022, 10.1128/JCM.00432-15 Hutchison, 2000, Endotoxic activity of lipopolysaccharides isolated from emergent potential cystic fibrosis pathogens, FEMS Immunol Med Microbiol, 27, 73, 10.1111/j.1574-695X.2000.tb01414.x Anderson, 1990, Effect of disinfectants on pseudomonads colonized on the interior surface of PVC pipes, Am J Public Health, 80, 17, 10.2105/AJPH.80.1.17 Adley, 2005, Biofilm formation in high purity water: Ralstonia pickettii a special case for analysis, Ultrapure Water, 22, 14 Pawar, 2015, In vivo efficacy of antimicrobials against biofilm-producing Pseudomonas aeruginosa, Antimicrob Agents Chemother, 59, 4974, 10.1128/AAC.00194-15 Kerem, 2005, Consensus Committee. Standards of care for patients with cystic fibrosis: a European consensus, J Cyst Fibros, 4, 7, 10.1016/j.jcf.2004.12.002 Steinberg JP, Burd EM. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, Eighth Edition. 2015. p. 2667–83. Fernandez-Olmos, 2012, MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients, J Cyst Fibros, 11, 59, 10.1016/j.jcf.2011.09.001 Coenye, 2003, Classification of Ralstonia pickettii-like isolates from the environment and clinical samples as Ralstonia insidiosa sp. nov, Int J Syst Evol Microbiol, 53, 1075, 10.1099/ijs.0.02555-0 Adley, 2005, Comparison of bioMerieux API 20NE and Remel RapID NF Plus, identification systems of type strains of Ralstonia pickettii, Lett Appl Microbiol, 41, 136, 10.1111/j.1472-765X.2005.01737.x Daxboeck, 2005, Characterization of clinically isolated Ralstonia mannitolilytica strains using random amplification of polymorphic DNA (RAPD) typing and antimicobial sensitivity, and comparison of the classification efficacy of phenotypic and genotypic assays, J Med Microbiol, 54, 55, 10.1099/jmm.0.45656-0 Ryan, 2011, Differentiating the growing nosocomial infectious threats Ralstonia pickettii and Ralstonia insidiosa, Eur J Clin Microbiol Infect Dis, 30, 1245, 10.1007/s10096-011-1219-9 Coenye, 2003, Classification of Ralstonia pickettii-like isolates from the environment and clinical samples as Ralstonia insidiosa sp nov, Int J Syst Evol Microbiol, 53, 1075, 10.1099/ijs.0.02555-0 De Soyza, 2010, Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience, J Heart Lung Transplant, 29, 1395, 10.1016/j.healun.2010.06.007 Degand, 2008, Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients, J Clin Microbiol, 46, 3361, 10.1128/JCM.00569-08 Alby, 2013, Comparison of matrix-assisted laser desorption ionization-time of flight (maldi-tof) mass spectrometry platforms for the identification of gram-negative rods from patients with cystic fibrosis, J Clin Microbiol, 51, 3852, 10.1128/JCM.01618-13 Marko, 2012, Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients, J Clin Microbiol, 50, 2034, 10.1128/JCM.00330-12 Clinical and Laboratory Standards Institute. M100-S25: performance standards for antimicrobial susceptibility testing. Twenty-Fifth Informational Supplement 2015. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2015. Ryan, 2013, The antibiotic susceptibility of water-based bacteria Ralstonia pickettii and Ralstonia insidiosa, J Med Microbiol, 62, 1025, 10.1099/jmm.0.054759-0 Girlich, 2004, OXA-60, a chromosomal, inducible, and imipenem-hydrolyzing class D beta-lactamase from Ralstonia pickettii, Antimicrob Agents Chemother, 48, 4217, 10.1128/AAC.48.11.4217-4225.2004 Gales, 2005, Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997–2002), Mem Inst Oswaldo Cruz, 100, 571, 10.1590/S0074-02762005000600011 Suzuki, 2015, Genome sequence of a carbapenem-resistant strain of Ralstonia mannitolilytica, Genome Announc, 3, 10.1128/genomeA.00405-15 Nordmann, 2000, Biochemical-genetic characterization and distribution of OXA-22, a chromosomal and inducible class D beta-lactamase from Ralstonia (Pseudomonas) pickettii, Antimicrob Agents Chemother, 44, 2201, 10.1128/AAC.44.8.2201-2204.2000 Gillow, 2006, Antibiotic resistance and identification of uncommon Gram-negative bacteria isolated from sputum of adult patients with cystic fibrosis, Br J Biomed Sci, 63, 22, 10.1080/09674845.2006.11978085 United States Food and Drug Administration. Fluoroquinolone antibacterial drugs for systemic use: drug safety communication - warnings updated due to disabling side effects. 2016 [11 August 2016]. Available from: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm513065.htm Zellweger, 2004, Failure of ceftriaxone in an intravenous drug user with invasive infection due to Ralstonia pickettii, Infection., 32, 246, 10.1007/s15010-004-3033-0 Kenning, 2009, In vitro activity of tigecycline and other commonly used antibiotics against Burkholderia cepacia complex and other multi-resistant, difficult-to-treat cystic fibrosis-associated Gram-negative non-fermentative bacteria, Clin Microbiol Infect, 15, S453 LiPuma, 2009, In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species, Antimicrob Agents Chemother, 53, 249, 10.1128/AAC.00691-08 Burns, 1998, Microbiology of sputum from patients at cystic fibrosis centers in the United States, Clin Infect Dis, 27, 158, 10.1086/514631 Levy, 2012, Non fermenters in CF samples. Ten years microbiology practice and results, J Cyst Fibros, 11, S83, 10.1016/S1569-1993(12)60276-8 Ferroni, 2002, Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center, J Clin Microbiol, 40, 3793, 10.1128/JCM.40.10.3793-3797.2002